Long-Term Pharmacologic Management of Atrial Fibrillation for Control of Rate and Rhythm

Prystowsky EN, Benson DW, Fuster V, et al. Management of patients with atrial fibrillation. Circulation 1996;93:1262–1277. Pritchett ELC. Management of Atrial Fibrillation. New England J Med 1992;326:1264–1271. Antman, EM. Atrial fibrillation and flutter: Maintaining stability of sinus rhythm versus ventricular rate control. J Cardiovasc Electrophys 1995;6:962–971. Rawles JM. What is meant by a “controlled” ventricular rate in atrial fibrillation? Br Heart J 1990;63:157–161. Falk RH, Leavitt JI. Digoxin for atrial fibrillation: A drug whose time has gone? Annals Int Med 1991;114:573–575. Falk RH, Knowlton AA, Bernard SA, Gotlieb NA, Battinelli NJ. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm: A randomized, double-blinded trial. Annals Int Med 1987;106:503–506. Rawles JM, Metcalfe MJ, Jennings K. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: Effect of digoxin. Br Heart J 1990;63:225–227. Murgatroyd FD, O'Nunain S, Gibson SM, et al. The results of CRAFT-1: A multi-center, double-blind, placebo-controlled crossover study of digoxin in symptomatic paroxysmal atrial fibrillation. J Am Coll Cardiol 1993;21:478A. Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Annals Int Med 1992;117:141–150. Flaker GC, Blackshear JL, McBride R, et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:527–532. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials. Circulation 1990;82:1106–1116. Hohnloser SH, Zabel M. Short-and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Am J Cardiol 1992;70:3A–10A. Anderson JL, Gilbert EM, Alpert BL, et al. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. Circulation 1989;80:1557–1570. UK Propafenone PSVT Study Group. A randomized, placebo-controlled trial of propafeneone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. Circulation 1995;92:2550–2557. Naccarelli GV, Dorian P, Hohnloser SH, Coumel P, for the Flecainide Multicenter Atrial Fibrillation Study Group. Am J Cardiol 1996;77:53A–59A. Feld GK, Chen P-S, Nicod P, Fleck RP. Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs. Am J Cardiol 1990;66:378–383. Juul-Möller S, Edvardsson N, Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation. Circulation 1990;82:1932–1939. Gosselink AT, Crijns HGM, Van Gelder IC, et al. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 1992;267:3289–3293. Chun SH, Sager PT, Stevenson WG, et al. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 1995;76:47–50. Wijffels MCEF, Kirchof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake, chronically instrumented goats. Circulation 1995;92:1954–1968. Middlekauff HR, Wiener I, Saxon LA, Stevenson WG. Low-dose amiodarone for atrial fibrillation: Time for a prospective study? Ann Intern Med 1992;116:1017–1020. Antman EM, Beamer AD, Cantillon C, McGowan N, Friedman PL. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: A staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol 1990;15:698–707. Reimold SC, Cantillon CO, Friedman PL, Antman EM. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol 1993;71:558–563. Ganz LI, Shea JB, Reimold SC, Cantillon CO, Friedman PL, Antman EM. Long-term follow-up in patients with medically refractory atrial fibrillation treated with propafenone and sotalol. J Am Coll Cardiol 1996;27:47A. van Gelder IC, Crijns HJGM, Heesen WF, et al. Atrial fibrillation in the elderly, is the same therapeutic strategy possible? J Am Coll Cardiol 1994; Special Issue:368A. Kall JG, Kopp DE, Kinder CA, Burke MC, Rubenstein DS, Wilber DJ. Sotalol versus low-dose amiodarone for maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 1996;27:46A. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects; A review with special reference to torsade de pointes tachycardia. Ann Int Med 1994;121:529–533. Laham RJ, Josephson ME. A prospective evaluation of the outpatient initiation of antiarrhythmic therapy for supraventricular tachyarrhythmias. J Am Coll Cardiol 1996;27:47A.